Tag: federal lawsuits

  • Inmates With Mental Health Issues Kept After Release Dates, Lawsuit Alleges

    Inmates With Mental Health Issues Kept After Release Dates, Lawsuit Alleges

    “Our clients are told, often on the day they expect to be released from prison, that they will not be leaving and must stay until community housing is located,” said the executive director of Disability Rights New York.

    In theory, MG is not in prison. His release date was in May 2017.

    And yet, every day he wakes up in a windowless cell in the Auburn Correctional Facility. He wears green prison clothes, stands for count and identifies himself by the seven-digit number emblazoned on his shirt.  

    That’s because MG is mentally ill and bound for community-based mental health housing—but there’s no space. So instead, the New York prison system has kept him, locking him up even after his sentence has technically ended. 

    But MG isn’t the only prisoner held long past the expiration of his sentence. That’s why the Legal Aid Society and Disability Rights New York last week filed a class action lawsuit against the state’s prison system, the New York State Office of Mental Health, the prison system and Governor Andrew Cuomo, claiming violations of the Americans with Disabilities Act and demanding that the state come up with better mental health housing options.  

    “Our clients are told, often on the day they expect to be released from prison, that they will not be leaving and must stay until community housing is located,” said Timothy Clune, executive director of Disability Rights New York. “Further, documents produced by the Defendants show that New York State is well aware of the shortage of mental health housing for this population. Instead of addressing this shortage the State has been ignoring the problem and our clients.”

    The six prisoners at the center of the new federal lawsuit are all mentally ill and at risk of homelessness, so the state decided they should be sent to supportive housing. But right now there isn’t enough, and when that happens, officials instead transfer prisoners like MG to one of 13 “residential treatment facilities”—all of which are in medium and maximum security prisons.

    In effect, according to the lawsuit, the prison system is lengthening their sentences because they’re mentally ill, in the process “undermining the most basic principle undergirding the criminal justice system: that a criminal sentence, once imposed by a judge, means what it says.”

    The state hasn’t responded in court to the legal claim just yet, and an Office of Mental Health official said they hadn’t been formally notified when reporters first started asking for comment.

    “This lawsuit was served to the media before it was served to us, so we can’t comment on its details,” spokeswoman Jessica Riley told The Albany Times-Union. “However, New York funds one of the most robust supportive housing networks in the nation for individuals with mental illness.”

    The state pours nearly $500 million a year into community-based housing for people with serious mental illness. Currently, that funds around 44,000 housing units statewide, and there’s plans to have 6,000 more online by 2021. 

    The other men in the lawsuit have stories similar to MG’s. 

    CJ, who has bipolar disorder, was supposed to get out of prison in September 2017—but he’s still locked up in the Green Haven unit in Stormville, according to the legal filing. He got a GED and vocational certificate during his time behind bars, and had hoped to get a job and rebuild a life for himself near his family in Orange County. Instead, he’s spent the past year-and-a-half in and out of barren psychiatric observation cells where he’s been put on suicide watch after repeatedly telling prison staff he’d rather die than stay in prison.

    MJ, who also has bipolar disorder, expected to get out in June 2018, according to court papers. Instead, he too was sent to Green Haven, where he’s been put in solitary twice for rules infractions—even though he shouldn’t be in prison to begin with.

    JR has depressive disorder and post-traumatic stress. He’s repeatedly attempted to harm himself, and he should already be out of prison—but he’s still at the Fishkill Correctional Facility in Beacon. Prison staff have already asked him to sign release papers and told him he’s considered a parolee instead of an inmate, even though he’s still in prison, the suit claims.

    DR, who has bipolar disorder, was slated for release in December 2017.

    Yet, he’s still being held at the Fishkill facility, the suit alleges. He proposed living with his aunt, but officials denied him and insisted that he must wait for community-based mental health housing to open up, according to the federal claim.

    It’s stories like these that prompted the legal advocates to file suit. They’re asking for class status; an order declaring the state’s actions unconstitutional; money for lawyers’ fees; and a permanent injunction forcing the state to make sufficient housing available and to come up with a better plan for mentally ill inmates in the future. 

    It’s not part of their requested relief but, as the suit notes: “Plaintiffs want to be free from prison.”

    View the original article at thefix.com

  • New Jersey Sues One Of Its Largest Employers Over Opioids

    New Jersey Sues One Of Its Largest Employers Over Opioids

    The lawsuit alleges that Janssen Pharmaceuticals minimized the risk of opioids and targeted older patients who were less aware of the dangers of the drugs.

    The pharmaceutical industry is a major economic driver for the state of New Jersey, but that did not stop the state’s attorney general from launching a lawsuit against Janssen Pharmaceuticals, one of the state’s largest employers, over its marketing practices around opioids.

    “It is especially troubling that so much of the alleged misconduct took place right here in our own backyard,” New Jersey Attorney General Gurbir Grewal said at a news conference, according to the New York Times. “New Jersey’s pharmaceutical industry is the envy of the world, with a long history of developing vital, lifesaving drugs. But we cannot turn a blind eye when a New Jersey company like Janssen violates our laws and threatens the lives of our residents.”

    The lawsuit alleges that Janssen minimized the risk of opioids, targeted older patients who were less aware of the dangers of the drugs, and made an effort to “embed its deceptions about the viability of long-term opioid use in the minds of doctors and patients.”

    The lawsuit focuses on the eight-year period that Janssen marketed two opioid products — Nucynta and Nucynta ER — before selling the rights to those medications for more than $1 billion in 2015. 

    Grewal said that the company intentionally fostered misinformation about those drugs. 

    “They funded bogus research,” he said. “They pushed bogus theories like pseudo-addiction, things that have been debunked. They positioned Nucynta and Nucynta ER as the safer alternative to other more powerful opioid drugs and, as the director mentioned, in fact, they were the same types of opioid drugs.”

    The lawsuit points out reportedly egregious prescribing practices, including one patient received 125 prescriptions for two opioids in just one year, totaling a 2,700-day supply of opioid pills. The doctor who wrote those prescriptions had taken hundreds of visits from Janssen representatives, the lawsuit said. 

    The pharmaceutical industry in New Jersey has shrunken slightly amid the opioid crisis, but still makes up about 8% of jobs in the state. However, Grewal said that did not factor into his decision over whether or not to pursue a lawsuit. 

    “We’re not shying away from holding folks accountable,” Mr. Grewal said. “If they’re culpable, we’ll hold them accountable.”

    This is the first time that New Jersey has taken legal action against a company based in the state, the New York Times reported. However, it’s not the first opioid-related lawsuit in the state. Former Governor Chris Christie’s administration launched legal action against Purdue Pharma and Insys Therapeutics, another opioid manufacturer. 

    View the original article at thefix.com